Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001171843-26-006472

Chief Executive Officer acquired 6,893 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nijhawan Pardeep Chief Executive Officer 2026-10-05 Grant or award +6,893 905,993 D: show line 1 in the form
Loading xslF345X06/ownership.xml…